Wayne State University
Wayne State University Dissertations
January 2020

The Relationship Between Excessive Folic Acid Intake And
Genome Instability In Human Lymphocytes
Khadijah Ibrahim Alnabbat
Wayne State University

Follow this and additional works at: https://digitalcommons.wayne.edu/oa_dissertations
Part of the Nutrition Commons

Recommended Citation
Alnabbat, Khadijah Ibrahim, "The Relationship Between Excessive Folic Acid Intake And Genome
Instability In Human Lymphocytes" (2020). Wayne State University Dissertations. 2433.
https://digitalcommons.wayne.edu/oa_dissertations/2433

This Open Access Dissertation is brought to you for free and open access by DigitalCommons@WayneState. It has
been accepted for inclusion in Wayne State University Dissertations by an authorized administrator of
DigitalCommons@WayneState.

THE RELATIONSHIP BETWEEN EXCESSIVE FOLIC ACID INTAKE AND
GENOME INSTABILITY IN HUMAN LYMPHOCYTES
by
KHADIJAH ALNABBAT
DISSERTATION
Submitted to the Graduate School
of Wayne State University,
Detroit, Michigan
in partial fulfillment of the requirements
for the degree of
DOCTOR OF PHILOSOPHY
2020
MAJOR: NUTRITION& FOOD SCIENCE
APPROVED BY:

______________________________________
Advisor

Date

______________________________________
______________________________________
______________________________________

DEDICATION
I would love to dedicate this dissertation to my loving and supportive family

ii

ACKNOWLEDGEMENTS
I would like to express my deepest gratitude to my advisor, Dr. Ahmad R.
Heydari. I was fortunate enough to be his student and learn from his knowledge. Without
his patience, support, and compassion, this dissertation would not have even been
possible. I would like to thank my committee members, Dr. Ashok Bhagwat, Dr. Diane
Cress, and Dr. Smiti Gupta, for their time and willingness to serve on this committee.
I want to thank Dr. Diane Cress for her support and kindness throughout my entire
graduate journey. I was lucky to learn and gain knowledge from her during the master’s
mentorship. I would like to thank Andrew James for his support, kindness, assistance,
and companionship through this journey.
Many thanks to lab members, Aiman Shahab, Dr. Manhel Albahri, my friends,
Eno, Wala, Bayan, Meliani, Nouf, and fellow undergraduate students, Raiza, Iris,
Helaina, and Hannah. I want to thank Raquel C., Riahana, and Chantae from GLML for
their kindness and assistance.

iii

TABLE OF CONTENTS
DEDICATION……………………………………………………………………………ii
ACKNOWLEDGEMENTS………………………………..……………………………iii
TABLE OF CONTENTS…………………………………..…………………………….iv
LIST OF TABLES…………………………………………..…………………………......v
LIST OF FIGURES…………………………………………..………………………......vi
CHAPTER 1: BACKGROUND & SIGNIFICANCE…………………………………..1
CHAPTER 2: THE IMPACT OF SUPRAPHYSIOLOGICAL CONCENTRATION
OF FOLIC ACID ON GENOME STABILITY OF HUMAN LYMPHOBLASTOID
CELL LINE IN VITRO…………………………………………………………………...10
CHAPTER 3: THE RELATIONSHIP BETWEEN EXCESSIVE FOLIC ACID
INTAKE AND GENOME INSTABILITY IN HUMAN LYMPHOCYTES OF
HEALTHY ADULTS, FUNCTIONAL FOLATE DEFICIENCY…………………..34
CHAPTER 4: SUMMARY & FUTURE DIRECTION……………………………….85
APPENDIX A…………………………………………………………………………….88
APPENDIX B…………………………………………………………………………….89
APPENDIX C…………………………………………………………………………….90
REFERENCES…………………………………………………………………………..91
ABSTRACT……………………………………………………………………………..107
AUTOBIOGRAPHICAL STATEMENT……………………………………………..109

iv

LIST OF TABLES
Table 2.1: Detailed description of lymphoblastoid cell lines (LCLs)…………………….33
Table 3.1: Description of main characteristics of study subjects…………………………57
Table 3.2: Summary of significant correlations between cytome biomarkers and other
variables…………………………………………………………………………………...66
Table S3.1A: Description of Model 1, serum folate tertiles………………………………74
Table S3.1B: Description of Model 2, total folate intake tertiles…………………………74
Table S3.1C: Description of Model 3, FA intake tertiles…………………………………75
Table S3.1D: Description of Model 4, FAR tertiles……………………………………...75
Table S3.2: Mean nutrient intake of study participants…………………………………..76
Table S3.3: Mean systemic markers of study participants………………………………..77
Table S3.5: Comparison between RBC folate and RBC indices between genders……..78
Table S3.6: Correlation levels of conventional systemic markers related to folate status..78

v

LIST OF FIGURES
Figure 1.1: The conversion of FA to active form tetrahydrofolate………………………...6
Figure 1.2: Folate and FA absorption by small intestine…………………………………..7
Figure 1.3: Folate & FA metabolism pathways……………………………………………8
Figure 1.4: Schematic depiction the proposed model of the study…………………………9
Figure 2.1: Schematic diagram of Study design (1)……………………...……………….23
Figure 2.2: Doubling time of human LCLs in response to different FA concentrations..24
Figure 2.3: Homocysteine levels in response to different FA concentrations in human
LCLs………………………………………………………………………………………25
Figure 2.4: LINE-1 methylation levels in response to different FA concentrations in
human LCLs………………………………………………………………………………26
Figure 2.5: Cytome Biomarker frequency scores in response to different FA
concentrations in human LCLs…………………………………………………………...27
Figure 2.6: Schematic diagram of Study design (2)..……………………………………..28
Figure 2.7: Cytome Biomarker frequency scores in response to different FA
concentrations in human LCLs…………………………………………………………...29
Figure 2.8: Gene profiling in response to different FA concentrations…………………..32
Figure 3.1: Average recommended dietary intake of study participants………………..58
Figure 3.2: Cytome Biomarkers frequency in human lymphocytes based on FAR tertiles
(Model 4)………………………………………………………………………………….59
Figure 3.3: Global LINE-1 methylation level with respect to Model 4, FAR tertiles……60
Figure 3.4: PCA loading plot of the correlation between cytome biomarkers & specific
nutrient intakes……………………………………………………………………………61
Figure 3.5: PCA loading plot of possible surrogate markers and their relationship with
cytome biomarkers and FAR tertiles……………………………………………………...62

vi

Figure 3.6: Comparison of possible surrogate markers between second and third tertile of
FAR………………………………………………………………………………………..63
Figure 3.7: Comparison of prediction accuracy levels of possible surrogate markers…...65
Figure S3.1: Study design depicting initial recruitment aims and data collection
process……………………………………………………………..………………………67
Figure S3.2: Cytome Biomarker frequency in human lymphocytes based on serum folate
tertiles (Model 1)………………………………………………………………………….68
Figure S3.3: Cytome Biomarker frequency in human lymphocytes based on total folate
intake tertiles (Model 2)…………………………………………………………………..69
Figure S3.4: Cytome Biomarker frequency in human lymphocytes based on FA intake
tertiles (Model 3)………………………………………………………………………….70
Figure S3.5: PCA loading plot of possible surrogate markers and their relationship with
cytome biomarkers………………………………………………………………………..71
Figure S3.6: PCA loading plot of models tertiles and their relationship with cytome
biomarkers and conventional blood markers……………………………………………..72
Figure S3.7: Comparison of some gene expression profiling between the second and third
tertiles of Model 4, based on FAR………………………………...………………………73
Figure S3.8: PCA loading plot of systemic markers…………………………………..…79
Figure S3.9: PCA scoring plot of Model 1…………………………………………….......80
Figure S3.10: PCA scoring plot of Model 2……………………………...…………..…....81
Figure S3.11: PCA scoring plot of Model 3……………………………...……………......82
Figure S3.12: PCA scoring plot of Model 4……………………………...…………..…....83
Figure S3.13: PCA scoring plot of surrogate markers analysis by Model 4……………...84

vii

1

CHAPTER 1: BACKGROUND & SIGNIFICANCE
An optimal intake of dietary folate is essential since mammalian cells lack the
enzyme required for folate biosynthesis [5]. Folate plays major roles in cell proliferation,
protein synthesis, amino acid metabolism, and neurotransmitter synthesis, and all these
functions of folate are achieved by tetrahydrofolate (THF) and its derivatives [6].
Folic acid (FA), or pteroylglutamic acid, is a fully oxidized compound which exists
at an extremely low level in nature and was successfully synthesized by Angier and his
colleagues in 1945 in an attempt to cure pernicious anemia [7]. As a provitamin, FA must
be reduced in a two-step reaction by dihydrofolate reductase (DHFR) to be an active
vitamin, i.e., the naturally occurring form of folate; 5-methyl-tetrahydrofolate (5-methylTHF), and formyl-tetrahydrofolate (Formyl-THF) [1]. Upon activation to THF, FA can
participate in the body folate pool as acceptor or donor of a methyl group in various
pathways carried out by one-carbon metabolism, including DNA synthesis, DNA
methylation and methionine regeneration. The common understanding that the majority
of consumed FA is reduced to 5-MTHF emerged from early rodent studies, mostly rats,
as well as studies on tumors and cell cultures. However, applying this concept to humans
is very challenging. In addition to the high rate of enzymatic activity in rats, tumors and
cell lines also exhibit high enzyme activity, perhaps due to supplementation of media with
high FA concentration and high growth rate [3, 8]. In contrast, the activity of DHFR in
human liver was discovered to be very low; only 2% of activity was observed in rat liver
[3]. It appears that before the bioavailability of synthetic FA, the main physiological role
of DHFR was to convert 7,8-dihydrofolate 7,8-(DHF) generated in the reaction of
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thymidylate synthase (TS) to 5,6,7,8-THF (the active form) [9]. However, DHFR
acquired another role to convert FA to 5,6,7,8-THF, i.e., FA is reduced to 7,8-DHF and
then to 5,6,7,8-THF (Fig 1.1). DHFR activity is 850 times slower with FA as substrate
than with 7,8-DHF in rats and 1300 times slower in humans [3]. Also, human DHFR
activity was found to be 56 times slower with FA, and 35 times slower with 7,8-DHF
compared to that of rats [3]. Furthermore, FA is not only a poor substrate for DHFR,
but also a competitive inhibitor when 7,8-DHF concentration is high, and noncompetitive inhibitor when 7,8-DHF concentration is low [3]. This phenomenon was also
observed in rodents, human kinetics studies with recombinant DHFR [3, 10], and
bacterial enzyme studies as well [3, 11].
FA is widely used in multivitamin supplements and is well known to improve folate
status and cure anemia developed from folate deficiency [3, 12]. Moreover, FA
supplementation reduces neural tube birth defects (NTD), and this finding has led several
countries, including USA, Canada, and Chile, to implement mandatory fortification
programs of food with FA in bread, cereal and grain products [12]. Despite the successful
outcome in reducing NTD, overall 19-32% reduction [13, 14], and significant increase in
population serum folate, many concerns have been raised about the safety and any
unintended adverse outcome of exposing the entire population to high folic acid [15, 16].
Fortification programs aimed to increase the individual intake of folate to100-200 mcg/
day [12]. Nevertheless, several studies have reported that total folate intake over the
upper limit (UL),1 mg/ day is now prevalent in the U.S [15]. Sacco et al. reported that
children aged 1 to 3 years old exceed the UL intake in the U.S. [15] Besides other reports
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that showed an increment level of plasma unmetabolized folic acid (UMFA)[12], a
biomarker of excess FA intake[3] was found in consumers of supplements compared to
non-consumers as a result of the US fortification program. UMFA appearance in plasma
was found to be associated with an intake of 200 µg in a single dose, and several studies
have linked UMFA to several adverse health outcomes [17]. Postmenopausal women
who consumed a folate-rich diet and 400mcg/day of folic acid supplements had reduced
natural killer (NK) cytotoxicity and higher UMFA levels compared to those who
consumed lower supplementation and low-folate diet [18]. Sanchez et al. reported that
high serum folate concentration (>45.3 nmol/L) was associated with increased DNA
methylation of tumor suppressor gene p16 and DNA repair enzymes MLH1 and MGMT
[19]. A shred of growing body evidence is indicating the relationship between FA
supplementation, high FA intake and higher cancer onset and progression [16, 20], and
increased mortality rate[16, 17, 21]. Furthermore, high FA intake can mask vitamin B12
deficiency and exacerbate adverse health outcome and cognitive impairment risk ratio in
B12 deficient people [15-17].
The reported intakes exceeding the upper limit, either from fortified food alone or
a combination of fortified food and supplements, will escalate the chronic exposure of
several tissues to a high amount of unmetabolized FA. The low activity of DHFR in
human liver and a high level of FA supplementation may result in functional folate
deficiency, which would further escalate the deleterious effects associated with the
presence of UMFA in systemic circulation in a certain populations [1, 17].
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As more FA entering the cell through folate receptors (FRs) and/ or protoncoupled folate transport (PCFT), FA species will compete with 7,8-DHF and eventually
saturate and inhibit DHFR, leading to the reduction of THF species, and accumulation
of DHF which was also shown to be a potent inhibitor of methylenetetrahydrofolate
reductase (MTHFR) in pig liver [22]. Thus, 5,10 methylene-THF would be spared for
purine and pyrimidine synthesis leading to the decrease of 5-methyl-THF required for
homocysteine re-methylation reactions (see proposed model Fig. 1.2).
Folates, as other micronutrients, are suggested to have a U-shape effect with
deleterious effects with both low and high concentration, especially with colon cancer [4].
Mason and Tang reported that excessive FA intake increases colorectal cancer risk,
especially with the existence of precancerous lesions. [23].
An imbalanced diet, deficiency or excessive intake of some nutrients, is well
known to affect the whole genome [8]. These effects lead to abnormal gene expression,
chromosomal instability and eventually inherited mutations [24]. Micronuclei (MNi)
scoring assay, an indicator of genome instability and genotoxic events, is found to be very
sensitive to nutritional deficiency and excess. MNi frequency is found to increase rapidly
with folate depletion in vitro [25]. Also, MNi frequency appears to be inversely associated
with serum B12 in young females and positively associated with plasma homocysteine
levels in young males [26]. Homocysteine is a functional marker for folate deficiency,
while B12 is an essential cofactor for natural folate uptake and metabolism.
In this study, we hypothesized that the chronic and excessive exposure of FA
via fortified food consumption induces functional folate deficiency. We proposed that
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the consequent damage of this functional folate insufficiency at the cellular level resembles
the DNA damage observed in folate depletion in human lymphocytes despite the normal
systemic markers of folate status. This hypothesis is tested for the following reasons:
Specific Aims
Aim 1: To determine whether excessive FA intake in human lymphocytes
induces functional folate deficiency in vitro. We hypothesized that excessive FA
supplementation in human lymphocytes culture media induces DNA damage, similar to
folate depletion. This damage is observed as an increase in micronuclei (MNi),
nucleoplasmic bridges (NPB), and nuclear budding (NBUD) formation, cytome and
DNA damage biomarkers associated with folate depletion. These markers are also known
to be associated with events of DNA hypomethylation and impaired DNA repair
mechanisms [24].
Aim 2: To determine whether high intake of FA through fortified food is
associated with DNA damage in human lymphocytes in healthy adults. With
increasing concerns about UMFA, we proposed that chronic exposure of FA through
fortified food proposed induces functional folate deficiency and damage at the cellular
level despite normal serum folate, RBC folate, and homocysteine levels in human subjects.
We hypothesized that the high intake of FA is associated with high MNi, NPB, NBUD
score frequency in human lymphocytes of healthy adults.
Aim 3: To determine the relationship between folate deficiency-driven
genomic markers observed in human lymphocytes of healthy adults and traditional
systemic folate status. Based on the proposed U-shaped relationship between folate
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status and colorectal cancer specifically[23], there is an emerging need to find surrogate
markers for folate status that would predict cellular damage earlier, especially when we
look at some reports that indicated some tissues could be folate-depleted even though
systemic folate markers indicate folate adequacy [27]. Thus, as a comprehensive
phenotyping approach, the surrogate markers proposed for folate status such as MNi,
uracil misincorporation, and LINE-1 methylation would be good candidates [6]. We
hypothesized that there is a relationship between systemic markers and the genomic
markers tested in this study. This relationship would help define the surrogate markers
for folate status.

Figure 1.1: The Conversion of FA to active form tetrahydrofolate (THF). Two-step
reduction of FA by DHFR. The oxidized pterin ring of FA requires the loss of more
stabilization energy during the first reduction. Vmax for DHFR with FA is extremely
slower than with 7,8-DHF, regardless of the source of the enzyme. Glu, glutamate, [3].
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Figure 1.2 Folate and FA absorption by small intestine. A. Folate requires the
removal of the polyglutamated chain by GCPII as it cross the cellular membrane and
transport inside the cell by PCFT, which makes it less bioavailable than FA. B. Inside
the intestinal mucosa, folate readily transports to blood or slightly modified as 5methyl-THF (5-mTHF), whereas FA is required to be reduced twice by DHFR and
methylated to be transported as 5-mTHF. C. Most absorbed folate appears in the
blood as 5-mTHF, while most absorbed FA appears in the blood as unmetabolized
FA (UMFA), usually associated with ingestion of 200µg FA per dose. (the dotted
arrow indicates a small quantity present in the blood [1]).
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Figure 1.3: Folate and FA metabolism pathways. Folate enters the cell as 5-mTHF
and donates the methyl group for homocysteine re-methylation reaction before
participation in the folate cellular pool. FA enters the cell as UMFA and requires
reduction by DHFR before participation in the cellular folate pool [4].
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CHAPTER 2: THE IMPACT OF SUPRAPHYSIOLOGICAL
CONCENTRATION OF FOLIC ACID ON GENOME STABILITY OF HUMAN
LYMPHOBLASTOID CELL LINE IN VITRO
2.1 Abstract
Folate metabolism is pivotal for many cellular processes, including cell
proliferation, nucleotide biosynthesis, methionine regeneration, and epigenetic regulation.
Folate deficiency has been linked to several diseases, including neural tube defects
(NTD), cancer, and chromosome aneuploidy, such as Down syndrome. Several studies
suggested that folic acid (FA), a synthetic version of natural folate, has a U-shaped effect
on health and disease. Since FA was introduced into our diets in 1998 after mandatory
fortification of grain and grain products, several opinions have raised concerns about its
safety and toxicity level for humans. In this study, we evaluated the impact of high FA
intake (supraphysiological level) on the genome stability of human lymphoblastoid in vitro.
By utilizing CBMN assay, we found high concentrations of FA in media; media deficient
in FA resulted in a statistically significant increase in cytome biomarkers in LCLs cells;
interestingly, a U-shaped trend is observed between FA concentrations and cytome
biomarkers.
2.2 Introduction
Folate is a pivotal nutrient for mammalian cells that plays a fundamental role in
DNA metabolism. It is required for the synthesis of dTMP from dUMP and S-adenosyl
methionine (SAM) from methionine. There is accumulated evidence that under the
condition of folate deficiency, dUMP accumulated, leading to uracil incorporation into
DNA in place of thymine. Excessive uracil misincorporation into DNA may generate
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point mutation, single and double-strand breaks, and chromosome breakage[8, 28, 29].
In addition to the deleterious effect of uracil, folate (5-mTHF) is required for a constant
supply of methionine through the conversion of homocysteine in a B12-dependent
reaction. Therefore, a decrease in methionine regeneration leads to a decline in SAM
synthesis, a methyl donor essential for several cellular and DNA methylation reactions,
which in turn leads to alteration of the DNA methylation pattern, gene expression, and
eventually chromosome aberration [8, 30].
Since humans, as other mammalians, lack the enzyme for folate synthesis,
obtaining folate from a well-balanced diet is crucial. A typical western diet content of
natural folate can easily fall below the recommended intake (400 mcg/day) [31], especially
in low socio-economic population [32, 33]. Low serum and RBC folate in women of
childbearing age are associated with an increase in NTD [34, 35], which has led several
countries including USA to fortify grain and grain products with Folic acid (FA), a
synthetic stable version of folate[12]. However, despite the similarity in structure, FA is
handled differently than the natural form. Unlike folate, FA is required to be activated
into a two-step reduction by dihydrofolate reductase (DHFR) [36] and then can
participate in the folate pool for thymidylate and nucleotide synthesis. Further, the action
of methylenetetrahydrofolate reductase (MTHFR) is required to be converted into 5mTHF, the predominant form in the blood, in B2 dependent reaction [6]. Furthermore,
Patanwala et al. showed that most absorbed FA appears in the blood as unmetabolized
FA (UMFA)[1], which is also associated with the ingestion of a diet containing more
than 200 µg of FA [17]. UMFA is linked to several health issues, including reduced
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natural killer cytotoxicity in postmenopausal women [18] and in mice models [37]. The
presence and persistence of UMFA in the blood are thought to be the result of low DHFR
activity in general in human, as well as the inhibition effect of FA to DHFR. FA poses a
fully aromatic pteridine ring that imposes a greater barrier for DHFR than DHF. Also,
FA was found to be either a competitive inhibitor or an uncompetitive inhibitor based on
cellular DHF concentration. DHFR slow activity and inhibition effect with FA is not only
found in humans but also in rodents [3]. The common understanding that the majority of
consumed folic acid is reduced to 5-MTHF emerged from early rodent studies, mostly
rats, as well as studies on tumors and cell culture. This common belief led most
publications to use FA and folate interchangeably, then furthering confusion between the
benefits and consequences of both forms. Natural folate is less stable than FA, so it is
unlikely to consume a high amount of natural folate. However, due to its stability, FA
upper limit (UL) intake was set at 1000 µg DFE, a level at which FA can conceal B12
deficiency [6, 38, 39].
Folate deficiency can lead to elevated DNA damage and DNA hypomethylation,
which are both risk factors for cancer [40, 41]. However, several opinions have increased
Skepticism over the beneficial effects of high intake of FA (synthetic version), and its
deleterious effect in cancer progression, especially in colon cancer, which is mostly linked
to imbalanced folate status[16].
Folate, like other micronutrients, is suggested to have the so-called U-shaped
effect with deleterious effects with both low and high concentrations. Mason and Tang
reported that excessive folic acid intake increases colorectal cancer risk, especially with
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the existence of precancerous lesions[23]. In this study, we evaluated the impact of high
FA intake (supraphysiological level) on the genome stability of human lymphoblastoid in
vitro.
2.3 Materials and Methods
Cell culture
Human lymphoblastoid cell lines (LCLs) were obtained from Coriell cell
repositories. LCLs were cultured in RPMI-1640 (free FA) supplemented with 10%
dialyzed FBS, 1% penicillin/ streptomycin (5000 IU penicillin/ 5 mg streptomycin), 1%
glutamax and 1% sodium pyruvate and incubated in a humidified atmosphere with 5%
CO2 at 37° C. Cells were initially grown in a medium containing a final concentration of
300 nM FA for three passages before seeding cells in either 12, 180, 300, 2300, and 10,000
nM FA, as shown in study design (1), Fig 2.1.
Doubling Time
We calculated the population doubling time (DT), or the time required for a
culture to double in number, using the formula: DT=In2/In (Xe/Xb). T: the incubation
time in any units, Xb: the cell number at the beginning of incubation time, Xe: the cell
number at the end of the incubation time. Cells were seeded at three different
concentrations in a 12-well culture plate, and counted after 4hr, as 0 hr, and then for 24
hr, 48hr and 72hr using trypan blue and an automated cell counter, TC20 TM (Bio-Rad,
USA). DT is reported as the mean of 3 days.
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Homocysteine Assay
Cells were washed twice with ice-cold 1X PBS and then collected by
centrifugation at 2000 x g for 10 minutes at 4°C. The cell pellet was homogenized on ice
in 1mL ice-cold 1X PBS and centrifuged at 10,000 x g for 15 minutes at 4°C. The
supernatant was removed and stored on ice. The homocysteine level was determined by
a commercially available homocysteine ELISA kit (Cell Biolabs, San Diego, CA)
according to the manufacturer’s instructions.
LINE-1 Methylation Assay
Genomic DNAs were isolated using PureLink® Genomic DNA Mini Kit (Life
Technologies, Carlsbad, CA), following the manufacture’s protocols. LINE-1
methylation assay was performed using the Global DNA Methylation LINE-1 kit (Active
Motif, Carlsbad, CA). Briefly, 100 ng Msel digested genomic DNA was hybridized with
LINE-1 probe and immobilized to a streptavidin-coated plate. After binding of primary
and secondary antibodies and setting colorimetric reaction, data were obtained and
analyzed using a standard curve of methylated and non-methylated DNA.
Cytokinesis-block Micronucleus (CBMN)Assay
We followed the protocols of Thomas and Fenech (2011) [42]. Briefly, on the day
of assay, cells were washed twice in Hanks balanced saline solution (HBSS) and then
incubated in supplemented RPMI-1640 medium containing either 12, 180, 300, 2300, and
10000 nM final concentration of FA and at a final concentration of 4.5 µg/ml cytochalasin
B (Sigma Aldrich). After 24 hours, cells were harvested in duplicate using Cytospin 4
(Shandon) at 600 rpm for 5 min. Slides were air-dried, fixed, and stained using Shandon
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Kwik-Diff Stains (Thermo Scientific). Slides were cover-slipped using DPX Mountant
(Sigma Aldrich). The frequency of MNi, NPB, and NBUD (cytome biomarkers) was
determined in 2000 binucleated (BN) cells following the scoring criteria of HUMN
project guidelines[43]. Slides were coded and scored by two trained scorers who had no
access to the codes. Cytome biomarker scores were presented per 1000 Binucleated cells
(BN).
Exposure of LCLs to hydrogen peroxide and CBMN assay
We followed the protocols by Main et al. (2013)[44]. Briefly, on day 9 of the assay
outlined in Fig 2.6, cells were washed twice in HBSS. Then, cells were exposed in RPMI1640 medium supplemented with a final concentration of 100 µM hydrogen peroxide for
one hour. The cells were then washed again in HBSS and resuspended in RPMI-1640
cell culture media containing either 180, 300, and 2300 nM final concentration of FA
before exposure to CB to complete CBMN assay, as described earlier.
Gene Expression Analysis
The mRNA expression level of various genes was quantified using quantitative
real-time PCR (qPCR), PikoReal 96 (Thermofisher, Vantaa, Finland). Total RNA was
extracted from LCLs using TRIzol® Reagent (Gibco BRL, Rockville, MD). The isolated
mRNA was reverse transcribed using and following the protocols ImProm-IITM Reverse
Transcription System. Transcript of each gene was normalized to the geometric mean of
HPRT1 and ß-Actin. External standards for each gene were prepared by subcloning
using the TOPO® TA Cloning® kit (Invitrogen, Carlsbad, CA).
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Statistical Analysis
Results were presented as mean (± SEM) and analyzed using one-way ANOVA
for comparison between groups. Post hoc student t-test was applied for comparison
between two groups using the software MICROSOFT ®EXCEL, version 16. P-value <
0.05 was considered statistically significant.
2.4 Results
We evaluated genome instability in response to a wide range of FA concentrations
so that we were able to look into the U-shaped association. We determined five different
concentration from previously published studies, where 10,000 nmol/L represents the
supraphysiological level [17, 45], 180-300 nmol/L represents proposed optimal
physiological level [8, 46, 47], and 12 nmol/L represents the depletion level [8, 17]. Also,
2300 nmol/L will be included as the level supplementation at which routine media
generally used in cell culture practices.
Doubling Time
Generally, the DT of LCLs ranges between 18hrs to 36 hrs and is a good indicator
of the normal proliferation rate of these cells. While the average DT of cells grown under
conditions of 300, 2300 and 10,000 nM was 36 hrs, cells grown under 180 nM experienced
a longer time, P<0.05. FA-deficient LCLs (12 nM), as expected, encountered significantly
extended DT, P<0.05, i.e., reduced proliferation rate.
Homocysteine level
Homocysteine is a well-accepted marker as a functional indicator for folate
deficiency, yet it is not specifically a reflection of folate status. We evaluated the impact
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of high FA (10,000 nM) on LCLs and compared it to other proposed concentrations,
including depletion level (12nM). Surprisingly, we found no statistically significant
difference across different FA treatments, though, a trend of a U-shaped association was
observed.
LINE-1 Methylation Level
Folate deficiency is associated with an alteration in the methylation level of a long
interspersed nuclear element (LINE-1), a 64% lower methylation level. These mobile
parasitic genetic elements comprised 17% of the human genome, and their methylation
level is considered to be a surrogate marker of global genomic DNA methylation. We
investigated the impact of high FA intake on the LINE-1 methylation level. As shown in
Fig.2.4, there was a statistically significant decrease in methylation level in response to
both the supraphysiological level (10,000nM) and deficiency level (12nM) of FA. Though
the level of hypomethylation was variable between different LCLs, hypomethylation was
more prominent at the depletion level. However, the global methylation level of LINE-1
did not differ significantly between 180,300,2300 nM.
Cytome Biomarkers scores in response to different FA concentration
It is well documented that FA deficiency induces DNA damage that can be
measured by CBMN assay. This assay measures endpoints DNA damage, such as
micronuclei (MNi), a biomarker of chromosome breakage and/or whole chromosome
loss; Nucleoplasmic bridge (NPB), a biomarker of DNA misrepair and/or telomere endfusions; Nuclear bud (NBUD), a biomarker of elimination of amplified DNA and/or
DNA repair complexes. Crott et al. showed that a minimum of 120 nM of FA is required
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to lower the formation of MNi, NPB, and NBUD (cytome biomarkers) in primary human
lymphocytes. Our results indicated that in response to high FA concentration in media
and media deficient in FA, there was a statistically significant increase in Cytome
biomarkers in LCLs when compared with 180,300 and 2300 nM. Interestingly, a Ushaped trend was observed between FA concentration and cytome biomarkers in human
LCLs, as shown in Fig 2.5. Also, 300nM of FA concentration encountered the lowest
MNi and NPB scores when compared with 180 and 2300 nM of FA, p<0.05.
Cytome biomarker scores in response to different FA concentration after exposure to
hydrogen peroxide
Further, we wanted to compare among 180, 300, and 2300 nM of FA
concentration in terms of repair capacity after exposure to hydrogen peroxide, i.e.,
oxidative stress repair response. As shown in Fig. 2.6, we scored cytome biomarkers after
hydrogen peroxide exposure in 24- and 72-hour recovery periods for 300nM of FA and
only 72-hour recovery periods for 180, and 2300 nM of FA. The reason for this approach
was to test how vast cytome biomarkers differ when cells were incubated at both lower
and higher concentrations than the concentration at which the lowest cytome biomarkers
scored in our study, 300 nM FA, Fig 2.5. Our results, Fig 2.7, showed that at 300 nM
(T_300), there was no statistical difference between 24- and 72-hour incubation periods
in terms of MNi and NPB scores. However, compared to 300 nM, MNi and NBUD
scores were higher at 180 nM (T_180) and 2300 nM (T_2300) when incubated at 72
hours after H2O2 exposure, p<0.05.
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Gene expression analysis
High concentrations of FA (10,000 nM) in media showed a similar impact on the
gene expression level of tumor suppressor genes (p16 and p21), cell cycle checkpoint gene
(RAD21), and BER genes, as seen in Fig 2.8. Uracil is removed by uracil-DNAglycosylase 2 (UNG) and replaced with thymidine by DNA polymerase beta (ß-POL).
This impact was similar to FA deficiency (12 nM) where UNG and ß-POL expression
levels were higher than 180, 300, 2300 nM, p<0.05, but not significant for RAD21, p16,
and p21.
2.5 Discussion
In this study, two important outcomes emerged. First, the supraphysiological
concentrations of folic acid in media appeared to be genotoxic for LCLs in vitro.
Micronucleus index, utilized by CBMN assay in human cells, is one of the standard
cytogenetic and genetic toxicology tests [48]. MNi are derived from events that lead to
chromosome fragments or whole chromosome to lag behind anaphase throughout the
nuclear division[49]. In evaluating the cytome biomarkers, we saw a prominent increase
in MNi scores at 10,000 nM compared to 180, 300, 2300 nM FA, in Fig 2.5. To our
knowledge, no previously published studies have evaluated the toxic impact of the
supraphysiological level of FA concentration in media on human LCLs, i.e., MNi scores.
Considering the U-shaped association, the impact of high FA concentrations could be
similar to a deficiency level (12nM), indicating a functional deficiency, yet the underlying
mechanisms are yet to be known. However, by evaluating the effect of high FA
concentration on global LINE-1 methylation (Fig 2.4) and UNG-BER genes (Fig 2.8
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A&B), we can speculate that the increment in MNi formation could be linked to genomic
hypomethylation and uracil misincorporation events. The link between uracil
incorporation into DNA and the consequent generation of double-strand breaks (DSB)
was established by multiple studies. Constant removal of uracil by UNG, followed by
incomplete repair of generated gaps by ß-POL, lead to DSB, chromosome breakage and
chromosome loss[50, 51], which eventually would be eliminated from the nucleus as MNi
expressed in the cytoplasm[2, 48, 49]. We saw an increase in UNG and ß-POL gens
expression levels, but this finding needs to be further confirmed with protein expression
analysis, uracil quantification assay [52] or UNG-BER assay. Nonetheless, our RAD21
gene expression level results did not show a significant difference across the five different
concentrations (Fig 2.8 E), though a trend was observed. RAD21 was shown to involve
in cellular S-phase arrest and consequent repair of DSB by homologous recombination
(HR) and sister chromatid cohesion[53]. It was suggested that DSB induced by FA
deficiency is unlikely to be repaired by HR in which BRCA1 and BRCA2 genes play an
important roles [8, 54]. This drives the importance to investigate (a) whether DSBs are
induced by high FA concentrations in LCLs, and (b) whether the misrepair of DSBs is
an underlying mechanism of MNi formation in response to high FA concentrations.
Further experiments using comet assay and y-H2AX are required. Henry et al. showed
that both super FA (10 mg/kg) and FA deficient diets (0.1 mg/kg) for 5 months had a
similar impact on mice (succinylsulfathiazole treated), where similarly both had
compromised nucleotide metabolism, pyrimidine metabolism, low lymphocytes number,
especially B-cells[55]. In addition to uracil misincorporation, hypomethylation of DNA
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has been linked to folate deficiency and MNi formation. Hypomethylation of CpG island
leads to heterochromatin defects, centromere instability, and chromosome malsegregation
and eventual loss as MNi[8, 24, 49]. Our data showed that hypomethylation was induced
when cells incubated in high concentrations of FA as well as in FA deficient media, i.e.,
low LINE-1 methylation level (Fig 2.4). The hypomethylation of LINE-1 pattern across
the five FA concentrations was similar between different LCLs (listed in Table 2.1), with
a degree of variation. These results support the finding of Charles et al. that the
supraphysiological level of FA reduced LINE-1 methylation level significantly in human
lung fibroblast and colon epithelial cell lines, and the impact was passage dependent [45].
The hypomethylation effect induced by the supraphysiological level of FA could be
explained by the limited capacity of cellular DHFR and MTHFR to reduce FA to 5mTHF, the active form required for methionine regeneration and SAM synthesis. Even
though the DHFR activity in vitro is over more expressed in human liver tissue [56], the
LCLs capacity to handle FA in long term incubation is unknown. It was reported by
Christensen et al. that FA supplementation led to a significant decline in mRNA
expression and protein activity of MTHFR in mouse models. The decline of MTHFR
activity effectively reduced 5-mTHF concentrations in high FA-fed mice compared to
controls [57]. It was also reported that FA supplementation leads to the inhibition of
MTHFR in crude brain extract [58], as well as in crude liver extract [57], suggesting that
UMFA could lead to MTHFR deficiency. Few studies have investigated the impact of
high FA concentrations on different human tissues in vitro, so further studies are required.

22

The second outcome this study showed was that moderate folate deficiency has a
strong effect on the genome stability of LCLs once exposed to genotoxic agents, such as
hydrogen peroxide. We showed that MNi and NBUD formation increased significantly
in cells exposed to hydrogen peroxide and incubated for 72 hour in 180 and 2300 nM FAmedia compared to 300 nM FA-media, Fig 2.7. This could indicate that folate status
impairs DNA repair response and/or interferes with the cytotoxic cellular response. Thus,
finding the optimal concentration to grow LCLs is very important for proper research
planning and data interpretation. Based on our results, 300nM appears to be an optimal
concentration of FA in media for LCLs with respect to proliferation rate, homocysteine
level, cytome biomarkers, and expression of stress response genes.
Given together our results, the supraphysiological concentrations of FA in LCLs
media-induced negative impacts on genome stability in vitro in a pattern appeared to be
similar to those of FA deficiency. A U-shaped association was observed in terms of cytome
biomarkers in response to FA status. The findings of this study support the concerns
raised by others about the safety of prolonged exposure to excessive amounts of FA in the
diet through fortified food.
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Figure 2.1: Schematic diagram of study design (1). An outline of the long-term culture and
assays tested the cytotoxic and genotoxic effects of supraphysiological concentration of folic
acid was compared to deficiency, proposed optimal, and routine media level on LCLs. FA, folic
acid, HC, homocysteine, gDNA, genomic DNA, CBMN, cytokinesis blocked micronucleus
assay.
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Figure 2.2: Doubling time of human LCLs in response to different FA
concentrations. LCL (GM16113). Data were presented as mean (± SEM), n=3.
Values with different superscripts indicate significant differences at p<0.05.
ANOVA P<0.001.
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Figure 2.3: Homocysteine levels in response to different FA concentrations in human
LCLs. LCL (GM16113). Data presented as mean (± SEM), n=3. Values with different
superscripts indicate significant differences at p<0.05. ANOVA P= ns.
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Figure 2.4: LINE-1 methylation levels in response to different FA concentrations in
human LCLs. The level of 5-mC % associated with detectable CpG residues was
measured by LINE-1 methylation assay. LCL 1 (GM16118), LCL 2 (GM16113), LCL
3 (GM00130). Data presented as mean (± SEM), n=3. Values with different superscripts
indicate significant differences at p<0.05. ANOVA P<0.001
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Figure 2.5: Cytome biomarker frequency scores in response to different FA
concentrations in human LCLs. MNi, NP & NBUD scores were measured by
CBMN assay as of study design (1). Scores represented per 1000 binucleated (BN)
cells. LCL (GM16113). Data presented as mean (± SEM), n=3. Values with
different superscripts indicate significant differences at p<0.05. ANOVA P<0.001.
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A

B

Figure 2.6: Schematic diagram of Study design (2). An outline of the long-term
culture and CBMN assay tested the cytotoxic and genotoxic effects of hydrogen
peroxide (H2O2) on LCLs, (GM16113). CB: cytochalasin-B. A: scores for C_300, and
T_300 (24 hr.) were collected. B: scores for T_300, T_180, and T_2300 (72 hr.) were
collected.
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Figure 2.7: Cytome biomarkers frequency scores in response to different FA
concentrations in human LCLs. MNi, NP & NBUD scores were measured by
CBMN assay as of study design (2). Scores represented per 1000 binucleated (BN)
cells assay. T: treatment, C: control, 180: 180 nM, 300: 300 nM and 2300: 2300 nM
(folic acid concentration). LCL (GM16113). Data presented as mean (± SEM), n=3.
Values with different superscripts indicate significant differences at p<0.05.
ANOVA P<0.0001.
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Figure 2.8: Gene profiling in response to different FA concentrations. A-E.
Gene expression was evaluated in LCLs (GM16113) grown in triplicate. Transcript
levels were determined using RT-qPCR and normalized to geometric mean of ßActin and HPRT1. A. UNG: Uracil-DNA glycosylase 2. B. ß-POL: DNA
polymerase beta. C. p21: Cyclin-dependent kinase inhibitor 1. D. p16: cyclindependent kinase inhibitor 2A. E. RAD21: Double-Strand-Break Repair Protein
Rad21 Homolog. Data are presented as mean (± SEM), n=3. ANOVA P<0.0001.
Values with different superscripts indicate significant differences at p<0.05.
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Table 2.1: detailed description of lymphoblastoid cell lines (LCLs).
LCLs

Type

Tissue

Gender

Age

Ethnicity

GM00130

Control/normal

B-lymphocyte

male

25yr.

Caucasian

GM16113

Control/normal

B-lymphocyte

male

27 yr.

Caucasian

GM16118

Control/normal

B-lymphocyte

male

21 yr.

Caucasian
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CHAPTER 3: THE RELATIONSHIP BETWEEN EXCESSIVE FOLIC ACID
INTAKE AND GENOME INSTABILITY IN HUMAN LYMPHOCYTES OF
HEALTHY ADULTS, FUNCTIONAL FOLATE DEFICIENCY
3.1 Abstract
Mandatory fortification of grain and grain products with synthetic folic acid (FA)
was initiated in the U.S. in 1998 in an attempt to reduce neural tube defects (NTD). Since
the introduction of FA fortification, there has been a significant increase in serum and red
blood cells (RBC) folate levels in the U.S. associated with a 19-31% reduction in NTD.
However, despite the reduction in NTD, several studies have shown a significant increase
in the onset of colon and rectal cancer over this period. Unlike the natural form of folate,
FA as a provitamin is required to be activated in a two-step reduction by dihydrofolate
reductase (DHFR), a very slow process in human tissues. Thus, most absorbed FA
appears in the blood as unmetabolized FA (UMFA). Furthermore, several studies have
implicated UMFA with reduced natural killer cells and cancer progression. In this study,
we proposed that the chronic and excessive exposure to FA via fortified food induces
functional folate deficiency, resulting in genomic instability. Herein, we evaluated the
correlation between high intake of FA via fortified food and the level of genome
damage/instability in lymphocytes of healthy adults by cytokinesis-block micronucleus
(CBMN) assay. In our study, we found a significant correlation between the highest
tertile of FA intake (>200µg DFE, Dietary folate equivalent) and increased micronuclei
(MNi), nucleoplasmic bridge (NPB) and nuclear buds (NBUD) scores (r = 0.38, 0.39
and 0.3, respectively). Whereas we observed a strong inverse correlation between low FA
to total folate intake ratio (FAR) < 0.35 and the aforementioned markers (r = -0.43, -0.61
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and -0.38), we also observed a strong positive association between high FAR > 0.5 and
the aforementioned markers (r = 0.69, 0.67 and 0.51), respectively. Our data suggest that
excessive FA intake and high FAR were associated with elevated genomic instability, i.e.,
an increase in cytome biomarkers, imitating folate deficiency.
3.2 Introduction:
Folate is an essential vitamin present naturally in green vegetables, liver, legumes
and in some fruits. It acts as a cofactor for several enzymes involved in DNA biosynthesis,
repair and maintenance [59, 60]. Impaired folate metabolism or folate deficiency has been
linked to NTD [61] and carcinogenesis in a wide range of tissues, including breast, cervix
and colon [40, 62, 63]. Several countries, including the U.S., Canada and Chile, have
mandated fortification programs of grain and grain products with folic acid FA, a
synthetic version of folate, in order to mitigate NTD [12, 16]. Even though there has been
a successful reduction in NTD (50% in Chile, 46% in Canada and 19-31% in USA) [16],
the number of cancer cases has increased steadily. For instance, colon cancer, which is
widely studied and linked to folate deficiency, has increased rapidly in the U.S. after the
mandatory fortification implementation, especially in younger generations[64], as well as
in Chile [21]. Several researchers have pointed out that DNA methylation abnormalities
are mostly the candidates explaining the link between folate and acrolectal cancer [4, 65,
66]. Folate (5-mTHF) is vital for the constant conversion of methionine to Sadenosylmethionine (SAM), a methyl group donor for cellular and DNA methylation
pathways. Folate exists naturally as 5-mTHF or 5-formyl-THF, which can also be
converted rapidly and efficiently by human intestinal mucosa to 5-mTHF. Unlike folate,
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FA must be activated and converted to 5-mTHF mainly by DHFR and
methylenetetrahydrofolate reductase (MTHFR) in multiple steps reactions [6, 36, 67].
This process of activation is very slow in humans, as illustrated by Patanwala et al. and
Bailey et al., which makes most of absorbed FA appear in the blood as unmetabolized FA
(UMFA), and this form has been found to persist in the blood even after 12 hours of
fasting indicating poor handling by human tissues for FA [1, 3]. Once inside the cell,
UMFA is capable of acting as a competitive and uncompetitive inhibitor for DHFR,
depending on DHF concentration inside the cells [3]. DHF is generated naturally inside
the cells during thymidylate synthesis, and it was found that DHFR coexists and shares
transcription factors with thymidylate synthase (TS) [68, 69]. Therefore, the continuous
inhibition of DHFR by FA leads to the accumulation of DHF molecules, which was
shown to be a potent inhibitor of MTHFR in pig liver as demonstrated by Matthews et
al. [70]. Further, the U-shaped association of FA intake has been implicated in several
deleterious outcomes, including colon cancer [4, 71]. Accordingly, we proposed that the
chronic and excessive exposure of FA through fortified food induces functional folate
deficiency and consequent genomic instability at the cellular level of human lymphocytes.
In addition, the severity of this impact depends greatly or partially on the amount of
natural folate consumed with respect to genetic variability in folate absorption and
metabolism-related enzymes and their relative cofactors, such as B12, B2, B3 and B6.
Lymphocytes (Lymph) are widely accepted as a suitable cellular source to
examine the effect of folate status on genome instability markers, such as strand breakage,
microsatellite instability, hypomethylation, and uracil misincorporation[72]. The CBMN
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assay developed by Fenech et al. provides a comprehensive and well-validated method to
measure endpoints of DNA damage, such as: MNi, biomarkers of chromosome breakage
and/ or chromosome loss; NPB, biomarkers of DNA misrepair and/or telomere end
effusion; NBUD, biomarkers of the elimination of amplified DNA and/or DNA repair
complexes [2, 48, 49]. MNi is a very sensitive measure of small changes in micronutrient
status, including folate, which makes it a robust biomarker to identify the impact of
excessive folate intake on genome stability.
Basten et al. showed that Lymph total folate is highly sensitive to folate intake and
correlates with plasma 5-m-THF and homocysteine, but not with RBC folate which
indicate that lymph would be a better indicator to current changes in food intake [72].
However, to our knowledge, there is no available data about the lymph folate correlation
level after the intervention of synthetic FA. A study by Kim et al. showed that colon
folate correlates strongly with RBC folate and serum folate, but after the intervention
with FA this correlation level dropped significantly after 6 months and disappeared
completely after one year [73]. If this would be true for lymph tissues as well, it would
mean neither of the conventional markers would accurately predict the folate status of
lymph after the mandatory fortification. Hence, we need to find other markers that would
predict folate status accurately. Biomarkers of Nutrition for Development (BOND)
suggested in their folate review that MNi, uracil misincorporation and LINE-1
hypomethylation would serve as good surrogate markers for folate deficiency status [6].
Therefore, in this study, we evaluated the correlation level of excessive FA intake through
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consumption of fortified food on genome instability of human lymphocytes using CBMN
assay.
3.3 Materials and Methods
Recruitment and Data collection
A total of 57 induvials were recruited for this study. Participants were screened
using our food folate survey to estimate individual food habit and folic acid intake. This
study aimed to have 3 groups of population with 3 levels of folate intake as shown in Fig
S3.1. Our inclusion criteria were healthy adult between the ages of 18 and 40 years old.
Those undergoing a medical treatment for current disease, taking medications or drugs,
pregnant and lactating women, strict vegetarians, vegans, heavy alcoholics, heavy
smokers and B-vitamins or multivitamins consumers were excluded from this study.
Thirty-three individuals were included in the study. At the first visit, participants read
and signed informed consent, food diary instructions which were administered by trained
personnel. We asked participants to record food intake for two days (one weekday and
one weekend day) in the first week. Only those whose food intake analysis still met the
estimated intake were asked to provide two extra days of food intake for the following
week and donate blood samples. Participants anthropometric measurements were
obtained as well. This study was approved by Institutional Review Board (IRB), Wayne
State University, Detroit, MI.
Dietary Intake Measurements
Dietary intake was assessed using a 4-day food diary over two weeks (2 weekdays
and 2 weekend days). Participants were asked to indicate details about the food item,
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name, type, size, amount, labeling, recipe for home-cooked item, or the name of the
restaurant. The food diaries were reviewed with participants by trained personnel to
assure the portions and information of food were provided. Participants were contacted
whenever any missing critical information was needed about their intake.
Food Intake, Folic acid intake Analysis
Food intakes were analyzed using eSha food processor nutrition analysis software
[74] to attain macronutrient(protein), micronutrient (Iron, choline, B1, B2, B3, B6, B12,
Folate) intake. However, since the software does not discriminate between natural folate
and FA, we obtained the amount of FA from fortified food item by referring to Food Data
Central on the USDA website [75]. Only the items with the amount of total folate (µg
and µg DFE) that matched the eSha analysis software were considered.
Blood Samples Collection and Analysis
Participants donated their blood samples between 9:00 and 11:00 am after an
overnight fast and before having breakfast to avoid possible effects of variation by dietary
metabolites. Participants were also encouraged to drink water in the morning to avoid
misleading complete blood count (CBC) results. Blood samples were collected by a
certified phlebotomist; the samples were analyzed promptly either in our laboratory or in
certified medical laboratories [76]. The lab analyses performed were serum folate, RBC
folate, plasmatic homocysteine, serum B12, methylmalonic acid (MMA), plasmatic B2,
B6, and CBC.
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Cytokinesis-block micronucleus (CBMN) Assay
Blood samples were collected in K2-EDTA tube and processed within two hours
of collection. Lymphocytes were isolated using a density gradient medium (Lymphoprep
TM

, Stem Cell technologies, Germany). The CMBN assay in lymphocytes was performed

using the protocol of Thomas and Fenech (2011)[42]. Briefly, the isolated lymphocytes
were washed twice in a Hank balanced salt solution (HBSS), and then resuspended in
culture media. Cell concentration was estimated using an automated cell counter. Cells
were cultured at concentration of 1X106 cells/ml in RPMI 1640 medium with 10% FBS,
1% penicillin, 1% glutamax and 300nM FA). All cultures were prepared in duplicate.
Forty- four hours after phytohaemaglutinin (PHA) stimulation (45µg/ml), cytochalasinB (4.5 mg/ml) was added, and cells were harvested 28 hours later on slides using Cytospin
4 (Shandon). Two slides were prepared for each duplicate culture, air dried, fixed in
absolute methanol and stained using a Diff-Quick staining kit (Thermo Scientific). The
frequency of MNi, NPB and NBUD was determined in 2000 binucleated (BN) cells
following the scoring criteria of HUMN project guidelines [43]. Slides were coded and
scored by two trained scorers who had no access to the codes. Scores presented as per
1000 BN cells, appendix B.
LINE-1 Methylation Assay
Genomic DNAs were isolated within 2 hours of collection in K2-EDTA tube using
a PureLink® Genomic DNA Mini Kit (life technologies, Carlsbad, CA), following the
manufacture’s protocols. LINE-1 methylation assay was performed using a Global DNA
Methylation LINE-1 Kit (Active Motif, Carlsbad, CA).
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Gene Expression Analysis
After blood collection in a K2-EDTA tube, RNA later was promptly added to blood
samples in an attempt to protect mRNA from fast degradation. Total RNA population
was extracted from blood within 4 hours of collection using a RiboPureTM -Blood kit
(Ambion). DNase I digestion (8 U/µL) was performed to remove contaminating genomic
DNA from eluted RNA. The isolated mRNA was reverse transcribed using and following
the protocols of ImProm-IITM Reverse Transcription System. Various gene expression
levels were quantified using a real time quantitative polymerase chain reaction (qPCR),
PikoReal 96 (Thermofisher, Vantaa, Finland). The Cq values were normalized to the
geometric mean of HPRT1 and ß-Actin, and the gene expression was calculated using the
equation – expression level of gene X = 2-(∆∆Cq).
Statistical Analysis
Data are presented as mean (standard deviation). Mean comparison between two
groups was performed using t-test. Ad hoc model analyses were performed on log
transformed data using principle component analysis (PCA). One-way ANOVA was
used to compare the means of 3 groups with post hoc t-test analysis. Pearson correlation
coefficient was used to evaluate the correlation level between two variables. The receiver
operating characteristic (ROC) curve was used to determine the sensitivity, specificity
and area under the curve (AUC) to evaluate surrogate marker prediction levels. P-value
< 0.05 was considered statistically significant. All data were statistically analyzed using
the software programs SPSS 25.0 (IBM, Armonk, NY).
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3.4 Results
General Participants Characteristics
The demographic and anthropometric measurement characteristics of the subjects
in the study are listed in Table 3.1. The study was performed on 33 healthy individual
(mean age 30.8 years, 36.4% females). There were statistically significant differences
between males and females only in respect to body mass index (BMI) and waist to hip
ratio (WHR). While females had lower values, males tended to have higher values.
However, WHR values indicated most males were within the low-health risk ratio of
developing cardiovascular diseases. Also, there were significant differences between
genders in RBC count, hemoglobin (HGB), hematocrit (HCT) and RBC folate
(supplementary data). Females had higher mean RBC folate (708 µg/L) than males (551
µg/L). RBC folate correlated inversely with RBC count, HGB and HCT (r= -0.5, p<
0.0001).
The relationship between cytome biomarker frequency scores and individual
characteristics analysis indicated no significant association with MNi. However, BMI
correlated positively with NPB (r= 0.35, p<0.04) and NBUD (r= 0.3, p< 0.08).
Systemic Markers Analysis
The evaluation of blood markers revealed that mean serum folate (SF) and B12,
plasma B2 and B6 fell in the reference range. The absence of B12 deficiency was further
confirmed by normal MMA value despite the observation of elevated plasma
homocysteine (HC) level. Of the study population, 39% had moderate HC level (15-20
µmol/L), 33% high HC level (> 20 µmol/L), and 18% had high serum folate (> 20 µg/L).
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The prevalence of RBC folate above the reference range (> 628 µg/L) occurred in 33% of
participants. We also evaluated RBC indices for the presence of anemia and/or iron
deficiency. Mean RBC count, HGB and HCT were within the normal range. Other RBC
indices showed 33% macrocytosis (MCV > 100 fL) and 64 % hypochromia (MCHC < 32
g/dL), and 48% had high RDW-SD (> 46 fL), conditions that could be associated with
folate and B12 deficiencies.
Individuals Nutrient Intake Analysis
The mean intake of protein, choline, iron, B1, B2, B3, B6, B12, folate is shown in
Table S3.1 with RDA and AI reference. We evaluated the individual intake of the
aforementioned nutrients using recommended dietary intake values as they are fixed for
gender, age and population. The analysis of Fig 3.1 showed that aside from the variability
of folate intakes, most participants met 100 % RDI. Slightly lower intakes of choline and
B2 are indicated by the error bars. Conversely, protein and B12 intakes exceeded 150 %
RDI.
Models Analysis
The analysis of PCA for systemic markers indicated that RBC folate had a minimal
effect on the variation of the study population. Most of the variation was driven by SF,
HC, MCV, RDW, MCHC and B2 for first principle component (PC1), and Lymph,
Neut, WBC, MPV and B6 for PC2 as shown in Fig S3.5 and Fig S3.8. In addition, SF,
HC, MCV, RDW, MCHC intercorrelated significantly and strongly with each other as
expected, as shown in supplementary data. Since the relationships between folate status
and SF, HC, MCV, MCHC, RDW have long been established previously, we proposed
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4 ad hoc multivariate models using those markers to look into the relationship between
folate intake, FA intake and the ratio between folic acid and folate intake. The models
were generated based on the tertiles of serum folate (Model 1), total folate intake (Model
2), FA intake (Model 3) and FA to folate ratio (Model 4). The purpose of these models is
to compare cytome biomarker scores between each tertile and look into the correlation
level between each variable. The detailed descriptions of the models and PCA analysis of
the models are presented in supplementary data. The analysis of Model 3, based on FA
intake tertiles (Fig S3.3), revealed that a mean MNi score of the highest tertile was
statistically significant and higher than the lowest tertile. The highest tertile of folic acid
intake (>200 µg) correlated positively and significantly with MNi, NPB and NBUD (r=
0.39, 0.39, 0.3 p<0.05)), respectively. The lowest tertile of FA intake (< 100 µg) correlated
inversely and significantly with MNi (r= -0.39 p<0.01).
Model 4, based on FA ratio, analysis revealed a clear separation of all cytome
biomarkers between the third tertile and the first and second tertiles. Mean MNi, NPB
and NBUD differed significantly between the third tertile and first and second tertiles
(Fig 3.2) but were not statistically significant between the first and second tertiles.
Whereas the highest tertile of folic acid ratio (> 0.5) correlated positively and significantly
with MNi, NPB and NBUD (r= 0.69, 0.67 and 0.51, P<0.001) respectively, the lowest
tertile of FA ratio (< 0.3) correlated significantly and inversely with the aforementioned
cytome biomarkers ( r= -0.43, -0.61 and -0.38 p< 0.01), respectively.
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There were neither significant association between cytome biomarkers and other
models’ variables, nor significant results obtained from Model 1, based on serum folate,
and Model 2, based on total folate intake as well (Fig S3.2 & Fig S3.3).
LINE-1 methylation level of Model 4:
We proposed that the functional folate deficiency induced impaired methylation
associated with increment in genome damage. We utilized the LINE-1 methylation level
as a surrogate marker for global genome methylation. We found a reduction in mean
methylation level in the third tertile though it was not significant, p= 0.07, Fig 3.3.
Gene expression Analyses:
We performed gene expression analyses for 6 genes in an attempt to compare the
second and third tertiles of folic acid ratio because they were more homogeneous; no
significant difference was observed between these tertiles in BMI level. As shown in Fig
S3.4, we found a 0.5-fold increase in O-6-methylguanine-DNA methyltransferase
(MGMT) gene expression level in the third tertile when compared with second and first
tertiles. This increase was also associated with a 1.5-fold increase in mutL homolog
1(MLH1), and 1-fold decrease in uracil DNA glycosylase (UNG) and cyclin-dependent
kinase inhibitor 2A, CDKN2A, known as p16. While MGMT, UNG, MLH1 are all genes
that participates in various DNA repair machinery, p16 is a tumor suppressor gene.
There

also

was

1.5-fold

increment

methelenetetrahydrofolate-reducatase

in

the

(MTHFR)

third

tertile

of

both

5,10-

and

5-methyltetrahydrofolate-

homocysteine methyltransferase (MTR), which is also known as Methionine synthase
(MS), a B12 dependent enzyme. Both MTHFR and MTR participate in folate
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metabolism and folate-methylation flux. However, these results were not statistically
significant.
Cytome biomarkers and specific nutrients intake Analysis
We looked into the association between cytome biomarkers and other B-vitamins,
iron, protein and choline intake. PCA analysis in Fig 3.4 indicated that there was an
inverse association between MNi, NPB & NBUD and choline (r= -0.33, -0.30 and -0.45
p< 0.01), and protein intake as well (r= -0.28, -0.25 and -0.47 p< 0.05), respectively.
Surrogate Markers analyses
Serum folate values did not provide discrimination between 5-mTHF and UMFA
and do not reflect current tissue status. In addition, since food diary intake method has its
limitations, we searched for other markers that would serve as surrogate markers for
folate status. Unlike RBC folate and RBC indices which reflect long term of tissues folate
storage (the last ~120 days), white blood cells (WBC) have a shorter life span (days to
weeks) [77]. We evaluated WBC count and WBC indices association in respect to cytome
biomarkers. PCA loading plot Fig S3.5 showed that MNi, NPB & NBUD correlated
positively with Lymph percentage (%) (r= 0.58, 0.50 and -0.55 p< 0.01) and correlated
inversely with Neutrophils percentage (Neut %) (r= -0.54, -0.63 and -0.53 p< 0.01),
respectively. They similarly correlated inversely with Neut /Lymph ratio (NLR) (r= -0.43,
-0.46 and -0.33 p< 0.001), respectively. Additionally, MNi correlated positively and
significantly with mean palatal volume (MPV) (r= 0.38, p< 0.01) and MPV to palatal
count (MPV/PC) (r= 0.3, p< 0.05), and NPB correlated negatively with WBC count (r= -
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0.4, p< 0.01). NPB and NBUD correlated positively with Monocytes percentage
(Mono %) (r= -0.4 and -0.26 p< 0.01).
Then, when we compared the fitting of the second and third tertiles of FAR to the
aforementioned surrogate markers, we found that the third tertiles correlated significantly
with WBC, Neut (%), Lymph (%), Mono (%), Palatal (PLT), MPV, MPV/PC and NLR
as follow: r(p)= -0.4 (<0.01), -0.61(<0.001), 0.68(<0.001), 0.24 (<0.01), -0.32 (0.03), 0.34
(0.02), 0.38 (0.01) and -0.62(<0.001). The second tertile correlated significantly with
WBC, Neut, Lymph, Mono, PLT, MPV, MPV/PC and NLR as follow: r(p)= 0.46
(<0.01), 0.60 (<0.001), -0.61 (<0.001),- 0.54 (<0.01), 0.36 (0.01), -0.43 (<0.001), -0.43
(<0.01) and 0.52(<0.001). The association between the surrogate markers and the third
tertile of FAR was similar to the association between those markers and cytome
biomarkers (Fig 3.5), whereas the second tertile was mutually opposite the third tertile
and cytome biomarkers.
Afterward, we compared the mean of each surrogate marker between the second
and third tertiles. Our data (Fig 3.6) indicated significant differences in terms of WBC,
Neut (%), Lymph (%), Mono (%) and NLR, but there were no significant differences in
terms of PLT, MPV, MPV/PC (p= 0.07) and LMR (p=0.06).
Furthermore, we used the receiver operator characteristic ROC curve to
discriminate among surrogate markers ability to predict the FAR (cut point > 0.50);
cytome biomarkers (cut point > 20-MNi,10-NPB and 10-NBUD). MNi, NPB and
NBUD intercorrelated strongly, r= 0.8, p< 0.0001 (data not shown). AUC provides a
meaningful interpretation about the accuracy of each measure [78], presented as mean
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with 95% confidence interval (CI). For FAR prediction (Fig 3.7A), Lymph (%) had
higher sensitivity, specificity, and AUC= 0.92 (0.8-1), p<0.001, 91% sensitivity and 76 %
specificity. The MPV/PC ratio had lower sensitivity and specificity, but AUC= 0.72 (0.550.89), p=0.03, 75% sensitivity and 62 % specificity. For the prediction of cytome
biomarkers (Fig 3.7B), only Lymph (%) had a great AUC = 0.89 (0.78-1), p<0.001, with
82% sensitivity and 86 % specificity.
Finally, we compared the mean of first tertile and second tertile of FAR. Besides
the significant difference in BMI mean (SD) 28.8 (4.8),and 23.5 (3.6), p<0.05, they
significantly differ in Mono (%) 8.9 (1.7) and 6.4 (1.3), p<0.05, and in LMR 3.98 (0.8)
and 4.86 (1.4), p<0.05, respectively. The first tertile of FAR correspondingly correlated
significantly with Mono (r= 0.28 p= 0.04) and with LMR (r= -0.38 p= 0.01). BMI also
correlated to similar degree with Mono (r= 0.29 p= 0.04), and the Mono AUC analysis
for BMI > 30 kg/m2 was 0.75 (0.58-0.92) p=0.02 (Fig 3.7C) with 80 % sensitivity and 53%
specificity.
3.5 Discussion
The association between folate deficiency and cytome biomarkers in human
lymphocytes has long been established, as well as adequate folate status as a precursor for
genomic stability has also long been determined. Several studies evaluated the impact of
FA deficiency/adequacy on MNi, NPB and NBUD formation in human lymphocytes in
vitro [8, 25, 79, 80]. Thus, the assumption of the benefit of high folate intake in the diet
was indomitable. However, studies examined this association in vivo, by evaluating either
serum folate, RBC folate, homocysteine level or folate intake, have found conflicting
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results. Also, we are not aware of any published studies that have examined the impact of
excessive FA intake on MNi, NPB and NBUD formation in human lymphocytes in vitro
or in vivo. Besides, most food intake studies evaluated total folate intake, or FA intake
without elucidating the amount of natural folate and the synthetic form. Therefore, the
primary aim of this study was to determine whether excessive intake of FA through the
consumption of fortified food is associated with genome instability in human lymphocytes
of healthy adults.
We proposed that excessive FA intake would induce functional folate deficiency
and consequential DNA damage. We evaluated the relationship between serum folate,
total folate intake, FA intake, FAR to total folate intake and DNA damage as indicated
by the presence of cytome biomarkers. Our analyses indicated that neither serum folate
nor RBC folate correlated with cytome biomarkers which corroborates the finding of
Fenech et al [8, 26, 81]. The analysis of mean cytome biomarkers between serum folate
tertiles and total folate intake tertiles revealed no significant differences; those findings
are similar to the findings of Fenech et al.[81] but also disagree with the results of other
studies [82, 83]. The disagreement can be explained by the approach of each study. Both
studies compared MNi to the baseline where the folate intake is below the recommended
level, i.e., high MNi is related to folate deficiency. Serum folate is known to correlate
strongly with folate intake, and both parameters do not distinguish between natural form
of folate or the synthetic one [34, 72]. A study by Ladeira et al. used food a frequency
questionnaire and found no significant correlation between total folate intake (mean 401
± 24 µg) and MNi, NPB and NBUD [84]. Therefore, we compared the mean of cytome
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biomarkers based on the tertiles of FA intake and FAR tertiles. Our results denoted
significantly higher MNi, NPB and NBUD frequencies in the highest tertile of FA intake
(>200 µg DFE) when compared with the lowest tertile (<100 µg DFE). To our
knowledge, there is no published data that elucidates the effect of FA intake alone as food
fortificant on genome damage in humans.
High MNi, NPB and NBUD frequencies were observed in the highest tertile of
FAR (>0.5) when compared with second and first tertiles (<0.35). Also, FAR > 0.5
correlated strongly with cytome biomarkers with the lower ratio (< 0.35) appearing to
provide protection from those biomarkers. The findings of the current study support our
proposal that excessive FA intake induces a functional folate deficiency and this
insufficiency is resolved by the interference of 5-mTHF (natural folate) species from
natural sources. We are not aware of any published data that consider the ratio of FA to
natural folate intake, yet a model that supports our data is Methotrexate (MTX), a
chemotherapeutic drug used to treat some cancers and rheumatoid arthritis. MTX is a
DHF analog that inhibits DHFR. Thus, treatment with low dose of MTX yields side
effects that mimic folate deficiency[85]. In addition, the result of the study by Shahin et
al. evidently indicated that MTX treatment significantly induced MNi frequency in bone
marrow cells of MTX-treated rats as well as in peripheral blood cells of MTX-treated
rheumatoid arthritis patients [86]. Madhyastha et al. also demonstrated that Leucovorin,
folinic acid (5-formyl-THF), has a protective effect against MTX-provoked MNi
formation in rat bone marrow, i.e. supplementation with Leucovorin following MTX
treatment decrease the formation of MNi significantly [87]. Our data showed similar
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observation that low FAR had a protective effect and was associated significantly with
lower formation of MNi, NPB and NBUD as well. This observation can be explained
that the lower the FAR, the higher the natural folate intake. Since the natural form, either
5-m-THF or 5-f-THF, does not require the action of DHFR to be activated [60], its
function is unaffected by the inhibition of DHFR by excess FA intake. Therefore, natural
folate allows the synthesis of purine/pyrimidine even in the absence of DHFR activity,
and in turn, normal DNA replication/repair and RNA transcription processes can
proceed[87]. Additionally, 5-m-THF surpasses FA in terms of feeding the cellular
methylation pathway. It donates a methyl group once entering the cell in B12-dependent
reaction to convert homocysteine to methionine in SAH to SAM pathway without
reliance on DHFR activity [36]. Hence, less genome damage was induced, i.e., less
cytome biomarkers, were observed in the first and second tertiles of FAR.
Homocysteine and B12 were found previously to correlate positively and inversely
with MNi scores in lymphocytes of male adults, respectively [26, 81]. In general, we did
not see in general a similar significant association pattern in our samples. This could be
due to the small size of our sample and/or due to the relatively variable and high mean
homocysteine level despite the normal values of serum folate, B12 and MMA. Little is
known about the effect of chronic exposure of FA in the diet on homocysteine level. This
difference could be explained that the reduction found in MNi in those studies was
attributed to the high rate of chromosomal damage at the baseline. Besides, those studies
were before the era of FA fortification, and there is little known about the impact of longterm FA supplementation on HC level, as is the case with mandatory fortification.
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However, HC level reached a plateau and increased again when RBC folate level
exceeded the reference range in elderly populations with Alzheimer disease [88]. This
could explain the high and wide variation in homocysteine level in our samples.
The relationship between HC, B12, FAR could indicate that the underlying
mechanism of MNi formation was attributed to hypomethylation events rather than DNA
breakage. We found no significant differences between UNG gene expression between
FAR tertiles, yet the third tertile was the lowest. CpG hypomethylation was shown to be
associated with MNi formation in healthy young males [26]. Hence, we evaluated the
methylation status using LINE-1 methylation as a surrogate marker of global genome
methylation [6]. LINE-1 hypomethylation was reflected with increasing MNi frequency
in human lymphocytes [89]. Charles et al. showed that a supraphysiological level of FA
induces LINE-1 hypomethylation in a tissue and passage dependent manner [45]. We
found no significant difference in LINE-1 methylation between FAR tertiles (p=0.07)
although a trend was observed, whereas the third tertile had the lowest methylation level.
Then, an analysis of nutrients intakes that have an impact on the activity of several
enzymes that regulate folate metabolism, such as B12 (MTR), B2 (MTHFR) and B6
(SHMT)[67]. According to the PCA analysis, only protein and choline intakes correlated
significantly and inversely with cytome biomarkers, which further supports our
hypothesis. Protein is essential for methionine intake, as choline is for the production of
betaine which remethylates homocysteine independently from B12 pathways[90, 91], and
therefore increases methylation reactions.
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MNi was proposed as a robust surrogate marker for folate status, but it is not
specific for folate unless combined with uracil misincorporation [6]. Unfortunately, at this
point we could not perform the analysis for uracil misincorporation, nor identify the
dNTPs pools ratio. Therefore, the secondary objective of the current study was to identify
conventional surrogate markers for folate status insufficiency that could be linked to
cytome biomarkers. Several studies have linked UMFA to several adverse health
outcomes in human, such as reduced natural killer (NK) cytotoxicity [18]. It has been
observed that either excessive or deficient folate status is related to alteration in the
immune response as illustrated by Henry et al. [55]. FA also is known to induce
lymphocytes generation in the bone marrow, and folate deficiency (FD) decreases WBC
count, neutrophils, and the subset of lymphocytes, where B-lymphocytes and neutrophils
are more sensitive to FD [92]. Moreover, FD has a direct impact on thrombocytes by
decreasing the palatal (PLT) count while increasing their mean volume [93, 94]. These
markers could be obtained as a component of CBC. Hence, we evaluated the relationship
between cytome biomarkers and some proposed surrogate markers. Then we compared
the mean of these surrogate markers between the second and third tertiles of FAR. We
found that Lymph (%), Mono (%), NLR and MPV/PC were higher in the third tertile of
FAR, while WBC, Neut (%) were lower in the third tertile. By examining the AUC of
each surrogate marker, only Lymph (%) was significant when we set the cutoff point at >
(20 MNi 10 NBP & NBUD). MPV/PC and Lymph (%) were significant when the cutoff
point set at > 0.5 FAR.
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The increase in Lymph (%) is associated with a simultaneous decrease in Neut
(%) which indicates a similar underlying mechanism. Lymph (%) (i.e., the ratio of Lymph
to WBC), which is considered to be a more accurate measure for immunity status than
Lymph count alone [95]. It is also affected by Neut and Mono counts which accurately
reflect the status of systemic anti-inflammatory surveillance, which inhibits tumor cell
proliferation. Low Lymph (%) was found to be associated with lung cancer progression
and as an independent prognostic factor in poor cancer treatment outcome[96].
Butin-Israeli et al. reported that Neutrophils can also encounter MNi formation
as a result of genome damage[97]. Rello-veronal et al. showed that MNi formed in the
cytoplasm can be sequestered and cleared by macroautophagy [98]. MNi was found to
induce innate immune response to be cleared through autophagy via cGAS-STING
pathway [99], DNA sensing machinery principal in the innate immune response [100].
Further research is needed to find which impact FD would have on this pathway as well
as which kind of interplay between mechanistic target of rapamycin (mTOR) pathways
for folate sensing, consequential autophagy and DNA sensing exists. Nonetheless,
autophagy has been found to play a vital role in the development and differentiation of
leukocytes and an essential role in lymph homeostasis by involving in the maintenance of
certain lymph subtypes [101]. Unlike other WBC species, autophagy has a negative
impact on Neut development and granulopoiesis[102, 103]. This would explain the
simultaneous decrease in Neut (%) with the increase in Lymph (%) in our data. The
decline in neutrophil count is common after chemotherapy, including MTX, albeit
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neutropenia was found to be exacerbated in patients with high serum folate level (>20
ng/ml).
MNi also can be caused by increased uracil misincorporation into DNA, strand
breakage or base lesions in DNA due to oxidative stress and alkylation [49]. MGMT gene
participates in the removal of O-6-methyl guanine in DNA as a result of alkylating agents,
one of which is S-adenosyl-methionine (SAM) as an endogenous source [104]. Defects
in DNA repair machinery and inappropriate expression of genes associated with cell cycle
checkpoints, such as p16, can induce MNi formation as well [24, 105]. Unfortunately, we
did not find any significant differences (supplementary data). This could be a result of
our method, i.e., isolating total transcript from whole blood. Therefore, sub fractioning of
the lymphocytes approach with stabilizing mRNA integrity is required.
Our data support the finding of Fenech et al. that BMI has no effect on MNi scores
[82]. However, we found that BMI has additive effects to NPB and NBUD scores as
appeared from the comparison between the first and second tertiles of FAR. Mono (%)
increased as a response of chronic inflammation or neutropenia. Chronic inflammation,
i.e., increases in leukocytes and monocytes numbers, is associated with obesity and
increased BMI as well [106, 107]. The significant intercorrelations between NPB,
NBUD, BMI and Mono (%) indicate an underlying mechanism that could be related to
chronic inflammation and oxidative stress. The high value of AUC for Mono (%) (Fig.S3)
suggests that Mono (%) could be a valid screening tool with BMI for NPB and NBUD.
In conclusion, our data indicated strong correlations between excessive and
chronic exposure to folic acid via fortified food and genome instability as well as an
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alteration in the immunity response, and this relationship resembled functional folate
deficiency. However, we are aware of the inherent limitation of food intake assessment
instruments, such as food intake diary. Thus, given the small size of our sample in the
current study, our results require further confirmation with a larger group of participants.
This is a prospective observational study, and our findings will help to concrete more
controlled clinical studies in the future.
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Table 3.1: Description of main characteristics of study subjects.
Characteristic
Age (years)
Males (%)
BMI (kg/m2)

WHR

N
33
21
33
M (21)
F (12)
33
M (21)
F (12)

Mean (SD)
30.80 (4.89)
63.6 %
26.14 (5.35)
27.9 (5.5)
23.7 (4.2) p = 0.03
0.85 (0.08)
0.88 (0.07)
0.78 (0.06) p< 0.001

Reference range:

Normal weight: 18.5-25
Overweight: 25-30
Obese: >30
Low health risk:
M < 0.9
F < 0.85

N, number of participants; SD, standard deviation; M, males; F, Females. BMI: body
mass index. WHR: waist to hip ratio. p-value refers to comparison between M &F.
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Recomended Dietary Intakes (RDI)
Protein
Choline
Iron
Folate DFE
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Vit. B12
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Figure 3.1: Average recommended dietary intake of study participants. Food
intake were obtained by food diary intake for 4 days and analyzed by eSha food
processor. Data were presented as mean (± SEM), n=33. Vit. B1: Thiamine intake
(mg), Vit.B2: Riboflavin intake (mg), Vit.B3: Niacin intake (mg), Vit.B6: Pyridoxin
intake (mg), Vit.B12: Cobalamin (mcg), Folate. DFE: total folate intake (mcg
DFE), Folate.mcg: total folate intake (mcg) Protein: protein intake (g), Choline:
Choline intake (mg), Iron: Iron intake (mg). DFE, dietary folate equivalent.
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Figure 3.2: Cytome Biomarker frequency in human lymphocytes based on FAR
tertiles (Model 4). MNi, NPB & NBUD scores were measured by CBMN assay,
scores represented per 1000 binucleated (BN) cells. LCL. MNi: micronuclei, NPB:
nucleoplasmic bridge, NBUD: nuclear bud. Lymphocytes were isolated from human
participants divided into tertiles (T1, T2, T3) based on folic acid intake to total folate
ratio (FAR). FAR were obtained by dividing folic acid intake on total folate intake.
Data were presented as mean (± SEM). Values with different superscripts indicate
significant differences at p<0.05. ANOVA P<0.001.
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Figure 3.3: Global LINE-1 methylation level with respect to model 4, FAR
tertiles. Level of 5-mC % was associated with detectable CpG residues in human
genomic DNA by LINE-1 methylation assay. Genomic DNA was isolated from
blood samples of study participants. Data were presented as mean (± SEM),
n=33. ANOVA= 0.07.
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Figure 3.4: PCA loading plot of the correlation between cytome biomarkers &
specific nutrients intakes. Food intake was obtained by food diary intake for 4 days
and analyzed by eSha food processor. MNi, NPB & NBUD scores were measured by
CBMN assay. Data were presented as mean (± SEM), n=33. PCA cumulative variance
explained (63.55%); PC1 (40.91%), PC2(22.64%), KMO=0.72, p-value < 0.0001.
MNi: micronuclei, NPB: nucleoplasmic bridges, NBUD: nuclear bud. Vit. B1:
Thiamine intake (mg), Vit.B2: Riboflavin intake (mg), Vit.B3: Niacin intake (mg),
Vit.B6: Pyridoxin intake (mg), Vit.B12: Cobalamin (mcg), Folate. DFE: total folate
intake (mcg DFE), Folate.mcg: total folate intake (mcg) Protein: protein intake (g),
Choline: Choline intake (mg), Iron: Iron intake (mg).
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Figure 3.5: PCA loading plot of possible surrogate markers and their relationship
with cytome biomarkers and FAR tertiles. PCA cumulative variance explained
(53.6%); PC1 (36.7%), PC2(16.9%), KMO=0.69, p-value < 0.0001. fa.r.T2: second
tertile of folic acid ratio, fa.rT3: highest tertile of folic acid to ratio. S.F: Serum Folate
(µg/L), HC: plasma Homocysteine (µmol/L), B2: plasma Riboflavin (µg/L), B6:
plasma Pyridoxal phosphate (µg/L), MCHC: Mean Corpuscular Hemoglobin
Concentration (d/dL), MPV: Mean platelet volume (fL), MPV/PC: MPV/ Platelet
count ratio. WBC: White blood cells (109/L), Neut: Neutrophils (%), Lymph:
Lymphocytes (%), Mono: Monocytes (%). MNi: Micronuclei, NPB: nucleoplasmic
bridges, NBUD: Nuclear bud.
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A

B

C

Figure 3.6: Comparison of possible surrogate markers between second and
third tertile of FAR. Data were presented as mean (± SEM), n=22. A, Neut:
Neutrophils (%), Lymph: Lymphocytes (%), PLT: Platelet count. B, WBC:
White blood cells (109/L), Mono: Monocytes (%), MPV: Mean platelet volume
(fL). C, a, values are multiplied with 100, p=0.06; b, p= 0.08. MPV/PC:
MPV/PLT, NLR: Neut/Lymph, LMR: Lymph/Mono. T2: second tertile of
FAR, T3: third tertile of FAR. * p< 0.01.
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Figure 3.7: Comparison of prediction accuracy levels of possible surrogate
markers. A, ROC curves of possible surrogate markers were in response to Folic
acid ratio (FAR > 0.5). B, ROC curves of possible surrogate markers were in
response to cytome biomarkers (> 20-MNi, 10-NPBs &10-NBUDs). C, ROC
curves of possible surrogate markers were in response to BMI > 30. Neut:
Neutrophils (%), Lymph: Lymphocytes (%), WBC: White blood cells (103/µL),
Mono: Monocytes (%), MPV/PC: MPV/PLT (MPV: Mean platelet volume (fL)/
PLT: Platelet count), NLR: Neut/Lymph, LMR: Lymph/Mono. Reference Line
=0.5. AUC, area under the curve, mean (95% CI). * p< 0.05, ** p<0.001.
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Table 3.2: Summary of significant correlations between cytome biomarkers and
other variables.
Pearson r
MNi
NPB
Characteristics:
BMI
ns
0.35 *
Nutrient Intake:
Folic acid (µg)
0.39 *
0.41 **
Folic acid ratio
0.68 ***
0.51 ***
Protein (g)
-0.28 *
-0.25 *
Choline (mg)
-0.33 **
-0.30 **
Models Tertiles:
fa.T1 (< 100 µg)
-0.39 **
ns
fa.T3 (> 200 µg)
0.39 **
0.39 **
fa.r.T2 (< 0.3)
-0.43 **
-0.61 ***
fa.r.T3 (> 0.5)
0.69 ***
0.67 ***
Surrogate markers:
WBC (103/µL)
-0.45 ***
-0.25 a
Neut (%)
-0.54 ***
-0.63 ***
Lymph (%)
0.58 ***
0.50 ***
Mono (%)
ns
0.32 *
MPV (fL)
0.37 *
ns
p-value: * <0.05, ** <0.01, *** <0.001, a= ns, ns: not significant.

NBUD
0.3 a
0.42 **
0.42 **
-0.47 *
-0.45 **
ns
0.3 *
-0.38 **
0.51 ***
-0.34 *
-0.53 ***
0.50 ***
0.32 a
ns

BMI: body mass index (kg/m2), fa.T: folic acid intake tertile (Model 3), fa.r.T: folic acid
intake ratio tertile (Model 4). WBC: White blood cells, Neut: Neutrophils, Lymph:
Lymphocytes, Mono: Monocytes, MPV: Mean platelet volume. MNi: Micronuclei, NPB:
nucleoplasmic bridges, NBUD: Nuclear bud.
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Supplementary Figures:
Initial Recruitment à Screening (Using designed Folate - Food Intake Survey) *
Recruitment
Aims

Low Folate
consumers
(<400 µg/d)
(<100 µg FA/d)

Moderate Folate
consumers
(400 - <600 µg/d)
(<220 µg FA/d)

High Folate
consumers
(³600 µg/d)
(>220 µg FA/d)

Figure S3.1: Study design depicting initial recruitment aims and data collection
process. N= number of participants, * Appendix A.
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Figure S3.2: Cytome Biomarker frequency in human lymphocytes based on
serum folate tertiles (Model 1). MNi, NPB & NBUD scores were measured by
CBMN assay, scores represented per 1000 binucleated (BN) cells. LCL.
Lymphocytes were isolated from human participants divided into tertiles (T1, T2,
T3) based on the serum folate level. Serum folate presented as µg/L (ng/ml). Data
were presented as mean (± SEM). ANOVA P.
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Figure S3.3: Cytome Biomarker frequency in human lymphocytes based on
total folate intake tertiles (Model 2). MNi, NPB & NBUD scores were
measured by CBMN assay, scores represented per 1000 binucleated (BN) cells.
LCL. MNi: micronuclei, NPB: nucleoplasmic bridge, NBUD: nuclear bud.
Lymphocytes were isolated from human participants divided into tertiles (T1, T2,
T3) based on total folate intake. Total folate intake presented as µg DFE (dietary
folate equivalent). Data were presented as mean (± SEM). ANOVA.

70

Figure S3.4: Cytome Biomarker frequency in human lymphocytes based on folic
acid intake tertiles (Model 3). MNi, NPB & NBUD scores measured by CBMN
assay, scores represented per 1000 binucleated (BN) cells. LCL. MNi: micronuclei,
NPB: nucleoplasmic bridge, NBUD: nuclear bud. Lymphocytes were isolated from
human participants divided into tertiles (T1, T2, T3) based on total folic acid intake.
Folic acid intake presented as µg DFE (dietary folate equivalent). Data were
presented as mean (± SEM). Values with different superscripts indicate significant
differences at p<0.05. ANOVA P<0.001.
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Figure S3.5: PCA loading plot of possible surrogate markers and their
relationship with cytome biomarkers. PCA cumulative variance explained
(53.1%); PC1 (33.8%), PC2(19.3%), KMO=0.65, p-value < 0.0001. S.F: Serum
Folate (µg/L), HC: plasma Homocysteine (µmol/L), B2: plasma Riboflavin (µg/L),
B6: plasma Pyridoxal phosphate (µg/L), MCHC: Mean Corpuscular Hemoglobin
Concentration (d/dL), MPV: Mean platelet volume (fL), MPV/PC: MPV/ Platelet
count ratio. WBC: White blood cells (109/L), Neut: Neutrophils (%), Lymph:
Lymphocytes (%), Mono: Monocytes (%). MNi: Micronuclei, NPB: nucleoplasmic
bridges, NBUD: Nuclear bud.
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Figure S3.6: PCA loading plot of model tertiles and their relationship with
cytome biomarkers and conventional blood markers. PCA cumulative variance
explained (63.9%); PC1 (33.9%), PC2 (30.0%), KMO- 0.76, p < 0.0001. T1-T3 :
tertiles. S.F: Serum folate (ng/µL), RBC.F : Red blood cells folate (ng/ µL). HC:
plasma Homocysteine (µmol/L), B2: plasma Riboflavin (nmol/L), MCV: Mean
Corpuscular Volume (fL), MCHC: Mean Corpuscular Hemoglobin Concentration
(g/dL), RDW.SD: Red cell Distribution Width- Standard deviation (fL). FA: Folic
acid from fortified food (µg DEF), FA.R : Folic acid: total food Folate Ratio. MNi :
Micronuclei, NPB : nucleoplasmic bridges, NBUD : Nuclear bud, (score/ 1000 BN
cells).
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Figure S3.7: Comparison of gene expression profiling between second and third
tertile of model 4, based on FAR. Total mRNA was isolated from blood samples
of participants divided based on folic acid intake ratio (FAR). T2 < 0.35, T3 > 0.5,
n=11. ANOVA= ns.
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Table S3.1A: Description of Model 1, serum folate tertiles.
Tertiles (n)

T1(11)

T2(11)

T3(11)

p- value

Serum Folate

9.3 (1.9)

14.4 (1.3)

20.6 (2.8)

< 0.0001

RBC Folate

563.5 (144.7)

571.6 (119.5)

689.9 (210.9)

0.14

Homocysteine

27.4 (7.2)

20.0 (6.2)

16.8 (6.3)

0.002

Folate

576.0 (339.4)

626.3 (336.4)

484.8 (209.4)

ns

Folic acid

204.2 (204.8)

233.7 (169.1)

187.1 (89.6)

<0.0001

Folic acid ratio

0.31 (0.01)

0.36 (0.01)

0.42 (0.02)

ns

MCV

101.3 (7.8)

92.7 (6.4)

89.6 (8.3)

< 0.0001

RDW-SD

51.5 (5.5)

45.3 (3.7)

43.0 (3.6)

0.003

MCHC

30.0 (1.9)

31.4 (1.6)

31.8 (1.3)

0.03

Table S3.1B: Description of Model 2, total folate intake tertiles.
Tertiles (n)

T1(11)

T2(11)

T3(11)

p- value

Folate

289.8 (73.4)

490.5 (59.4)

906.9 (237.9)

< 0.0001

Folic acid

98.6 (53.6)

152.2 (39.1)

374.2 (168.3)

< 0.0001

Folic acid ratio

0.36 (0.03)

0.32 (0.01)

0.41 (0.01)

ns

Serum Folate

13.9 (4.4)

15.4 (4.8)

15.0 (6.3)

ns

RBC Folate

637.2 (215.7)

571.3 (145.1)

616.5 (143.6)

ns

Homocysteine

25.5 (7.7)

19.0 (4.8)

19.6 (9.2)

0.09

MCV

96.8 (7.9)

93.9 (9.3)

92.9 (9.6)

ns

RDW-SD

48.2 (5.6)

45.1 (4.6)

46.5 (6.5)

ns

MCHC

30.2 (1.6)

31.9 (1.6)

31.2 (1.7)

0.07
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Table S3.1C: Description of Model 3, folic acid intake tertiles.
Tertiles (n)

T1(11)

T2(11)

T3(11)

p- value

Folic acid

85.6 (35.6)

155.9 (18.5)

383.4 (157.8)

<0.0001

Folate

362.4 (124.2)

503.9 (240.9)

820.7 (298.1)

<0.0001

Folic acid ratio

0.24 (0.01)

0.38 (0.02)

0.46 (0.01)

0.003

Serum Folate

13.9 (4.5)

14.5 (5.2)

15.9 (5.1)

ns

RBC Folate

583.7 (210)

605.6 (146.2)

635.7 (153.9)

ns

Homocysteine

24.1 (7.1)

21.4 (8.3)

18.8 (7.8)

ns

MCV

95.2 (7.2)

97.1 (9.5)

91.3 (9.4)

ns

RDW-SD

47.1 (5.8)

47.2 (4.8)

45.6 (6.4)

ns

MCHC

30.8 (1.9)

31.3 (1.6)

31.1 (1.8)

ns

Table S3.1D: Description of Model 4, folic acid intake ratio tertiles.
Tertiles (n)

T1(11)

T2(11)

T3(11)

p- value

Folic acid ratio

0.2 (0.06)

0.35 (0.04)

0.54 (0.02)

< 0.0001

Folic acid (DFE)

99.1 (51)

180.7 (92.5)

345.1 (184.5)

< 0.0001

Folate (DFE)

492.0 (253.9)

510.2 (240.4)

684.9 (369.1)

ns

Serum Folate

13.6 (4.8)

14.5 (5.2)

16.2 (5.5)

ns

RBC Folate

581.7 (205.8)

625.9 (144.2)

617.3 (168.4)

ns

Homocysteine

23.2 (7.0)

20.5 (7.8)

20.4 (8.9)

ns

MCV

94.7 (6.9)

96.3 (9.5)

92.6 (10.3)

ns

RDW-SD

46.9 (5.5)

46.2 (5.4)

46.6 (6.3)

ns

MCHC

31.4 (1.6)

31.1 (2.1)

30.8 (1.6)

ns
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Table S3.2: Mean nutrient intake of study participants.

a

Nutrient Intake

N

Mean (SD)

RDA or AI c

Protein (g)

31

89.3 (37.2)

0.8 g/kg/day

Choline (mg)

31

306.5 (130.5)

M: 550 mg/ day

F: 425 mg/day

Iron (mg)

31

14.9 (6.8)

M: 8 mg/ day

F: 18 mg/day

Vitamin B1 (mg)

31

1.31 (0.54)

M: 1.2 mg/ day

F: 1.1 mg/day

Vitamin B2 (mg)

31

1.22 (0.81)

M: 1.3 mg/ day

F: 1.1 mg/day

Vitamin B3 (mg)a

31

21.2 (10.2)

M: 16 mg/ day

F: 14 mg/day

Vitamin B6 (mg)

31

1.54 (0.92)

M: 1.3 mg/ day

F: 1.3 mg/day

Vitamin B12 (mcg)

31

4.94 (12.2)

M: 2.4 mcg/ day

F: 2.4 mcg/day

Folate (mcg)

33

401.76 (230.9)

Folate (mcg DFE) b

33

495.9 (303.8)

M: 400 mcg/ day

F: 400 mcg/day

Recommendation is expressed as niacin equivalent (NE)
Recommendation is expressed as dietary folate equivalent (DEF)
C
Recommendation are expressed as Recommended Dietary allowance (RDA) or
Adequate Intake (AI) for group ages (19-50).
b
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Table S3.3: Mean systemic markers of study participants.

a

Systemic Markers

N

Mean (SD)

Normal Rang

Serum folate (µg/L) a

33

14.8 (5.12)

2 - 20

RBC folate (µg/L) a

33

608.32 (168.4)

140 - 628

Homocysteine (µmol/L)

33

21.41 (7.82)

4 -15

Serum B12 (pg/ml)

33

459.5 (186.5)

200 - 950

MMA (nmol/L)

33

125.7 (49.1)

87 - 318

Plasma B6 (µg/L)

33

18.9 (15.4)

5 - 50

Plasma B2 (µg/L)

33

20.21 (23.6)

4 - 24

HGB (g/dL)

33

14.92 (1.81)

M: 13.5 -17.5

F: 12 - 15.5

HCT (%)

33

48.1 (5.7)

M: 42 - 54

F: 38 - 46

6

RBC (10 /L)

33

5.10 (0.6)

M: 4.7 - 6.1

F: 4.2 - 5.4

WBC (109/L)

33

6.26 (1.68)

4.5 - 11

Neut (%)

33

51.6 (10.7)

45 - 75

Lymph (%)

33

36.4 (8.9)

20 - 40

Mono (%)

33

8.1 (2.3)

2–8

MCV (fL)

33

94.6 (8.7)

80 - 96

MCH (pg)

33

29.3 (2.1)

23 - 31

MCHC (g/dL)

33

31.1 (1.74)

32 - 36

RDW-SD (fL)

33

46.6 (5.6)

39 - 46

PLT (103/µl)

33

264.3 (63.93)

150 - 400

MPV (fL)

33

11.19 (0.83)

7 – 11

to convert to nmol/l multiply by 2.6, µg/L= ng/µL.

78

Table S3.5: Comparison between RBC folate and RBC indices between genders.
Mean
(SD)
M
(21)
F
(12)
P

RBC
Folate
551.3
(122)
708
(195.6)
0.008

RBC

HGB

HCT

MCV

MCH

MCHC RDW
SD
31.4
45.9
(1.7)
(4.1)

RDW
CV
13.4
(1.6)

5.3
(0.6)

15.6
(1.7)

49.9
(5.1)

93.7
(7.2)

29.3
(1.8)

4.7
(0.5)

13.7
(1.4)

44.9
(5.3)

96
(11.5)

29.2
(2.6)

30.6
(1.8)

47.9
(7.6)

13.6
(1.12)

0.002

0.002

0.01

0.4

0.8

0.2

0.3

0.8

Table S3.6: Correlation levels of conventional systemic markers related to folate
status.
Pearson r

Serum Folate

Pa

Homocysteine

Pa

RBC Folate

0.36

0.02

-0.26

0.07

Homocysteine

-0.57

<0.001

NA

NA

MCV

-0.43

0.007

0.66

<0.001

MCHC

0.44

0.006

-0.73

<0.001

RDW-SD

-0.55

0.001

0.74

<0.001

a, 1-tail t-test, NA (not applicable).
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Figure S3.8: PCA loading plot of systemic markers. Cumulative variance
explained (58.4%); PC1 (33.6%), PC2(24.8%), KMO=0.7, p-value < 0.0001.
RBC.F: Red Blood Cells folate (µg/L), S.F: Serum Folate (µg/L), HC: plasma
Homocysteine (µmol/L), B2: plasma Riboflavin (µg/L), B6: plasma Pyridoxal
phosphate (µg/L), MCV: Mean Corpuscular Volume (fL), MCHC: Mean
Corpuscular Hemoglobin Concentration (g/dL), RDW-SD: Red cell Distribution
Width- Standard deviation (fL). MPV: Mean platelet volume (fL), WBC: White
blood cells (109/L), Neut: Neutrophils (%), Lymph: Lymphocytes (%).
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Figure S3.9: PCA scoring plot for Model 1. PC1 (38.0%), PC2 (25.7%), KMO=
0.72, p-value < 0.0001.
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Figure S3.10: PCA scoring plot for Model 2. PC1 (33.0%), PC2 (26.8%), KMO=
0.64, p-value < 0.0001.
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Figure S3.11: PCA scoring plot for Model 3. PC1 (35.0%), PC2 (27.8%), KMO=
0.72, p-value < 0.0001.
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Figure S3.12: PCA scoring plot for Model 4. PC1 (33.9%), PC2 (30.0%), KMO=
0.76, p-value < 0.0001
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Figure S3.13: PCA scoring plot for surrogate markers analysis by Model 4.
PC1 (36.7%), PC2(16.9%), KMO=0.69, p-value < 0.0001.

85

CHAPTER 4: SUMMARY & FUTURE DIRECTION
The finding of this study supports several concerns raised about the safety of folic
acid (FA), especially at high doses. Folate deficiency (FD) is known by the accumulated
evidence to induce DNA damage and carcinogenesis by several mechanisms. In addition
to several reports concerning FA and its safety at higher doses, the presence of
unmetabolized FA (UMFA) in the blood, which linked to several deleterious effects, led
to test the hypothesis that:
a) high doses of FA could lead to functional FD and consequence DNA damage.
Using the in vitro model, our data showed that FA has genotoxic effects to the cells. We
observed higher micronuclei (MNi), nucleoplasmic bridges (NPB) and nuclear buds
(NBUD) formation which indicates high genome damage. The pattern of damage
observed in cytome biomarkers is similar to FD.
b) excess FA intake through consumption of fortified food is associated with
higher cytome biomarkers, i.e., greater genome damage. Our results indicated that the
highest tertile of FA intake (> 200mcg) is associated significantly with an increase in
cytome biomarkers compared with the lowest tertile (< 100 mcg).
c) the natural form of folate would diminish the consequent damage of excess FA.
Our in vitro model showed the direct impact of excess FA (synthetic form) in media on
genome stability. It is hard to measure the impact of 5-mTHF in cell culture models due
to its low stability in the environment (media). Therefore, in the human study we
evaluated the association between FA ratio to natural folate as well. We found that the
higher the ratio (FAR > 0.5), the higher the damage (higher cytome biomarkers), albeit
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the lower the ratio (FAR < 0.35), the lower the cytome biomarkers. This association
suggests that the natural folate has a protective property against the genotoxic effects of
the synthetic form.
Given that we only observed this association using food diary intake, more
controlled intervention studies are needed to confirm our results. For future studies, we
need to consider several points:

a) the high variability of dihydrofolate reductase

(DHFR) activity in humans and methylenetetrahydrofolate reductase (MTHFR)
genotypes; b) the ratio of FA intake to natural form; c) the amount of natural folate
contributed from gut microflora (but less is known about this subject); and d) the need to
use alternative tests to evaluate folate status other than red blood cell (RBC) and serum
folate and homocysteine. For example, the histidine load test (FIGLU-test) could be
useful in the determination of the availability of tetrahydrofolate (THF).
Our results in no way indicate that the fortification program is harmful and should
be terminated. We acknowledge the importance of the program for the target high-risk
population that the program is intended to help. However, with our current knowledge
and advanced tools, the program should be re-evaluated. There are deep concerns about
the prolonged and high exposure of other vulnerable populations to FA, such as cancer
patients. We join our voice with others who question the safety of the current program.
We think several steps can be taken in this regard: a) mandate new regulation, such as:
targeting lower aim of fortification with FA, setting an upper limit for added FA in
manufactures, and limiting types of food that could be fortified; b) increasing public
awareness about FA and including the information and quantity of FA in food labeling;
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c) finding alternative ways to fortify food, for example, fortifying food with Nano encapsulated L-methyl folate or fortifying dairy products with some engineered probiotics
that produce a higher amount of natural folate in the colon through more researches in
this regard [4]; d) finding other parameters to monitor the program, other than RBC
folate, serum folate or homocysteine levels; e) perform mass-survey research to target the
food that contributes mostly to UMFA, and develop more validated food folate surveys
other than the DFE Block Survey.
The need to develop this work is not only related to the genotoxic effect of FA or
carcinogenesis. Other concerns should be addressed as well. For instance, there is a
higher chance that excessive FA intake exceeding the upper limit can disguise B12
deficiency and consequent cognitive impairments. The deleterious effect on mental health
and development cannot be reversed. This concerns for child development as well as that
of the elderly population. It was shown that 5-mTHF is the only form of folate that can
cross the blood-brain barriers [108], and with B12 deficiency, this issue is exacerbated.
Therefore, more work should be done to investigate the role of high FA intake on health.
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APPENDIX A
(Food-Folate Survey; Screening Tool)
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APPENDIX B
(Sampling and Scoring Plan for CBMN Assay)

A schematic showing the study approach for sampling and scoring for cytokinesis blocked micronucleus (CBMN) assay. The plan enables an estimation of experimental
variation and scorer bias, following the criteria of Fenech (2007 ) [2].
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APPENDIX C
(Cytome Biomarkers)
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ABSTRACT
THE RELATIONSHIP BETWEEN EXCESSIVE FOLIC ACID INTAKE AND
GENOME INSTABILITY IN HUMAN LYMPHOCYTES.
by
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Degree: Doctor of philosophy
Since its synthesis in 1945, Folic acid (FA) is widely used as a supplement/additive
to our food due to its stability and high bioavailability. FA is proposed to alleviate anemia
and reduce neural tube defects (NTD). As a provitamin, FA is activated through a twostep reaction catalyzed by dihydrofolate reductase (DHFR) in the folate metabolism
pathway. FA activation rate is found to be slow in humans. After the implementation of
mandatory food fortification program of grain and grain products with folic acid in the
USA in 1998, many concerns have been raised about the unintended deleterious
consequence of exposing the whole population to vast amounts of folic acid. These
concerns have been further escalated after several studies reported that upon fortification,
certain human populations are exceeding the UL intake of FA, resulting in an increase in
cancer rate (e.g., colon, stomach, and breast cancer) associated with an increment in
mortality rate. Furthermore, recent studies have proposed the U-shape effect of folic acid
on the onset and progression of cancer. In this study, we analyzed the correlation between
the high intake of folic acid and the level of genome damage in lymphocytes by utilizing
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the CBMN cytome assay in human and cell culture models, and their relation to folate
systemic markers. We hypothesized that the chronic and excessive exposure of folic acid
via fortified food consumption induces functional folate deficiency.
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